These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
349 related articles for article (PubMed ID: 19841474)
1. Pharmacological characterization of human incretin receptor missense variants. Fortin JP; Schroeder JC; Zhu Y; Beinborn M; Kopin AS J Pharmacol Exp Ther; 2010 Jan; 332(1):274-80. PubMed ID: 19841474 [TBL] [Abstract][Full Text] [Related]
2. The GIP receptor displays higher basal activity than the GLP-1 receptor but does not recruit GRK2 or arrestin3 effectively. Al-Sabah S; Al-Fulaij M; Shaaban G; Ahmed HA; Mann RJ; Donnelly D; Bünemann M; Krasel C PLoS One; 2014; 9(9):e106890. PubMed ID: 25191754 [TBL] [Abstract][Full Text] [Related]
3. Discovery of dual-action membrane-anchored modulators of incretin receptors. Fortin JP; Chinnapen D; Beinborn M; Lencer W; Kopin AS PLoS One; 2011; 6(9):e24693. PubMed ID: 21935440 [TBL] [Abstract][Full Text] [Related]
4. GIP and GLP-1 as incretin hormones: lessons from single and double incretin receptor knockout mice. Hansotia T; Drucker DJ Regul Pept; 2005 Jun; 128(2):125-34. PubMed ID: 15780432 [TBL] [Abstract][Full Text] [Related]
5. Localization of the domains involved in ligand binding and activation of the glucose-dependent insulinotropic polypeptide receptor. Gelling RW; Wheeler MB; Xue J; Gyomorey S; Nian C; Pederson RA; McIntosh CH Endocrinology; 1997 Jun; 138(6):2640-3. PubMed ID: 9165060 [TBL] [Abstract][Full Text] [Related]
6. Diabetes and obesity treatment based on dual incretin receptor activation: 'twincretins'. Skow MA; Bergmann NC; Knop FK Diabetes Obes Metab; 2016 Sep; 18(9):847-54. PubMed ID: 27160961 [TBL] [Abstract][Full Text] [Related]
7. Glucagon-like peptide 1 and glucose-dependent insulinotropic polypeptide stimulate release of substance P from TRPV1- and TRPA1-expressing sensory nerves. Mayer F; Gunawan AL; Tso P; Aponte GW Am J Physiol Gastrointest Liver Physiol; 2020 Jul; 319(1):G23-G35. PubMed ID: 32421358 [TBL] [Abstract][Full Text] [Related]
8. Selectivity of peptide ligands for the human incretin receptors expressed in HEK-293 cells. Al-Sabah S; Al-Fulaij M; Ahmed HA Eur J Pharmacol; 2014 Oct; 741():311-5. PubMed ID: 25179575 [TBL] [Abstract][Full Text] [Related]
9. Decreased TCF7L2 protein levels in type 2 diabetes mellitus correlate with downregulation of GIP- and GLP-1 receptors and impaired beta-cell function. Shu L; Matveyenko AV; Kerr-Conte J; Cho JH; McIntosh CH; Maedler K Hum Mol Genet; 2009 Jul; 18(13):2388-99. PubMed ID: 19386626 [TBL] [Abstract][Full Text] [Related]
10. Discovery of amino acid variants in the human glucose-dependent insulinotropic polypeptide (GIP) receptor: the impact on the pancreatic beta cell responses and functional expression studies in Chinese hamster fibroblast cells. Almind K; Ambye L; Urhammer SA; Hansen T; Echwald SM; Holst JJ; Gromada J; Thorens B; Pedersen O Diabetologia; 1998 Oct; 41(10):1194-8. PubMed ID: 9794107 [TBL] [Abstract][Full Text] [Related]
11. Effects of chronic exposure of clonal β-cells to elevated glucose and free fatty acids on incretin receptor gene expression and secretory responses to GIP and GLP-1. Pathak V; Vasu S; Flatt PR; Irwin N Diabetes Obes Metab; 2014 Apr; 16(4):357-65. PubMed ID: 24164718 [TBL] [Abstract][Full Text] [Related]
12. Pharmacological characterization of mono-, dual- and tri-peptidic agonists at GIP and GLP-1 receptors. Yuliantie E; Darbalaei S; Dai A; Zhao P; Yang D; Sexton PM; Wang MW; Wootten D Biochem Pharmacol; 2020 Jul; 177():114001. PubMed ID: 32360365 [TBL] [Abstract][Full Text] [Related]
18. Genetic and biased agonist-mediated reductions in β-arrestin recruitment prolong cAMP signaling at glucagon family receptors. Jones B; McGlone ER; Fang Z; Pickford P; Corrêa IR; Oishi A; Jockers R; Inoue A; Kumar S; Görlitz F; Dunsby C; French PMW; Rutter GA; Tan T; Tomas A; Bloom SR J Biol Chem; 2021; 296():100133. PubMed ID: 33268378 [TBL] [Abstract][Full Text] [Related]
19. Expression of glucagon-like peptide-1 receptor and glucose‑dependent insulinotropic polypeptide receptor is regulated by the glucose concentration in mouse osteoblastic MC3T3-E1 cells. Aoyama E; Watari I; Podyma-Inoue KA; Yanagishita M; Ono T Int J Mol Med; 2014 Aug; 34(2):475-82. PubMed ID: 24866833 [TBL] [Abstract][Full Text] [Related]
20. Receptors and effects of gut hormones in three osteoblastic cell lines. Pacheco-Pantoja EL; Ranganath LR; Gallagher JA; Wilson PJ; Fraser WD BMC Physiol; 2011 Jul; 11():12. PubMed ID: 21801348 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]